BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23111193)

  • 21. Benzene and lymphohematopoietic malignancies in China.
    Hayes RB; Yin S; Rothman N; Dosemeci M; Li G; Travis LT; Smith MT; Linet MS
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):419-32. PubMed ID: 11086948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzene and human health: A historical review and appraisal of associations with various diseases.
    Galbraith D; Gross SA; Paustenbach D
    Crit Rev Toxicol; 2010 Nov; 40 Suppl 2():1-46. PubMed ID: 20939751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers.
    Schnatter AR; Armstrong TW; Nicolich MJ; Thompson FS; Katz AM; Huebner WW; Pearlman ED
    Occup Environ Med; 1996 Nov; 53(11):773-81. PubMed ID: 9038803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzene exposure-response and risk of lymphoid neoplasms in Chinese workers: A multicenter case-cohort study.
    Linet MS; Gilbert ES; Vermeulen R; Dores GM; Yin SN; Portengen L; Hayes RB; Ji BT; Lan Q; Li GL; Rothman N
    Am J Ind Med; 2020 Sep; 63(9):741-754. PubMed ID: 32474961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemia risk associated with low-level benzene exposure.
    Glass DC; Gray CN; Jolley DJ; Gibbons C; Sim MR; Fritschi L; Adams GG; Bisby JA; Manuell R
    Epidemiology; 2003 Sep; 14(5):569-77. PubMed ID: 14501272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industries. Part XXX: Causal relationship between chronic myelogenous leukemia and benzene-containing solvents.
    Mehlman MA
    Ann N Y Acad Sci; 2006 Sep; 1076():110-9. PubMed ID: 17119196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers.
    Wong O; Raabe GK
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):188-99. PubMed ID: 9356282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzene exposure in the petroleum distribution industry associated with leukemia in the United Kingdom: overview of the methodology of a case-control study.
    Rushton L
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1371-4. PubMed ID: 9118922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-type-specific leukemia analyses in a combined cohort of more than 208,000 petroleum workers in the United States and the United Kingdom, 1937-1989.
    Wong O; Raabe GK
    Regul Toxicol Pharmacol; 1995 Apr; 21(2):307-21. PubMed ID: 7644720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens.
    Mundt KA; Dell LD; Boffetta P; Beckett EM; Lynch HN; Desai VJ; Lin CK; Thompson WJ
    BMC Cancer; 2021 Mar; 21(1):227. PubMed ID: 33676443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ensuring comparability of benzene exposure estimates across three nested case-control studies in the petroleum industry in support of a pooled epidemiological analysis.
    Glass DC; Armstrong TW; Pearlman ED; Verma DK; Schnatter AR; Rushton L
    Chem Biol Interact; 2010 Mar; 184(1-2):101-11. PubMed ID: 19914227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Acute Nonlymphocytic Leukemia and Its Subtypes With Updated Benzene Exposure and Mortality Estimates: A Lifetable Analysis of the Pliofilm Cohort.
    Rhomberg L; Goodman J; Tao G; Zu K; Chandalia J; Williams PR; Allen B
    J Occup Environ Med; 2016 Apr; 58(4):414-20. PubMed ID: 27058483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health Watch exposure estimates: do they underestimate benzene exposure?
    Glass DC; Gray CN; Jolley DJ; Gibbons C; Sim MR
    Chem Biol Interact; 2005 May; 153-154():23-32. PubMed ID: 15935797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study of leukemia among petroleum workers.
    Sathiakumar N; Delzell E; Cole P; Brill I; Frisch J; Spivey G
    J Occup Environ Med; 1995 Nov; 37(11):1269-77. PubMed ID: 8595496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 36. Butadiene cancer exposure-response modeling: based on workers in the styrene-butadiene-rubber industry: total leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia.
    Sielken RL; Valdez-Flores C
    Regul Toxicol Pharmacol; 2011 Aug; 60(3):332-41. PubMed ID: 21600953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
    Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphoma and exposure to benzene in a multinational cohort of more than 308,000 petroleum workers, 1937 to 1996.
    Wong O; Raabe GK
    J Occup Environ Med; 2000 May; 42(5):554-68. PubMed ID: 10824308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
    Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
    Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.